VolitionRx Limited (VNRX)

Price$2.65

Value ScoreC

Growth ScoreA

Momentum ScoreF

Favorite Metrics

Price vs S&P 500 (26W)-75.90%

Price vs S&P 500 (4W)4.90%

VGM Score47.06

Market Capitalization$20.99M

All Metrics

Book Value / Share (Quarterly)$0.07

P/TBV (Annual)9.49x

Revenue Growth (3Y)77.29%

Cash Flow / Share (Quarterly)$-2.62

Price vs S&P 500 (YTD)-58.68%

Net Profit Margin (TTM)-997.46%

EPS (TTM)$-4.22

10-Day Avg Trading Volume0.28M

EPS Excl Extra (TTM)$-4.22

Revenue Growth (5Y)180.21%

EPS (Annual)$-4.37

ROI (Annual)-122.64%

Net Profit Margin (5Y Avg)-9529.48%

Cash / Share (Quarterly)$0.39

Revenue Growth QoQ (YoY)299.81%

ROA (Last FY)-338.45%

Revenue Growth TTM (YoY)88.48%

EBITD / Share (TTM)$-3.65

ROE (5Y Avg)-136.80%

Operating Margin (TTM)-915.52%

Cash Flow / Share (Annual)$-3.14

P/B Ratio3.59x

P/B Ratio (Quarterly)18.58x

Net Income / Employee (Annual)$-311,400

EV / Revenue (TTM)12.05x

Net Interest Coverage (TTM)-8.44x

ROA (TTM)-316.46%

EPS Incl Extra (Annual)$-4.37

Current Ratio (Annual)0.17x

Quick Ratio (Quarterly)0.27x

3-Month Avg Trading Volume0.47M

52-Week Price Return-72.64%

Revenue / Employee (TTM)$32,900

Tangible BV / Share (Quarterly)$0.07

P/S Ratio (Annual)12.15x

Asset Turnover (Annual)0.25x

52-Week High$18.80

Operating Margin (5Y Avg)-9964.11%

EPS Excl Extra (Annual)$-4.37

CapEx CAGR (5Y)-45.94%

Tangible BV CAGR (5Y)-2.94%

26-Week Price Return-59.97%

Quick Ratio (Annual)0.13x

13-Week Price Return-43.19%

Total Debt / Equity (Annual)0.22x

Current Ratio (Quarterly)0.33x

Enterprise Value$29.71M

Revenue / Share Growth (5Y)338.27%

Asset Turnover (TTM)0.32x

Book Value / Share Growth (5Y)-16.26%

Revenue / Employee (Annual)$23,000

Pretax Margin (Annual)-1360.63%

Cash / Share (Annual)$0.18

3-Month Return Std Dev90.71%

Net Income / Employee (TTM)$-328,000

ROE (Last FY)-149.44%

Net Interest Coverage (Annual)-7.33x

EPS Basic Excl Extra (Annual)$-4.37

Receivables Turnover (TTM)11.21x

Total Debt / Equity (Quarterly)0.79x

EPS Incl Extra (TTM)$-4.22

Receivables Turnover (Annual)8.06x

ROI (TTM)-191.86%

P/S Ratio (TTM)8.51x

Pretax Margin (5Y Avg)-9606.40%

Revenue / Share (Annual)$0.32

Tangible BV / Share (Annual)$0.33

Price vs S&P 500 (52W)-100.85%

Year-to-Date Return-47.75%

5-Day Price Return-14.70%

EPS Normalized (Annual)$-4.37

ROA (5Y Avg)-202.93%

Net Profit Margin (Annual)-1352.17%

Month-to-Date Return1.91%

Cash Flow / Share (TTM)$-0.50

EBITD / Share (Annual)$-3.84

Operating Margin (Annual)-1258.47%

LT Debt / Equity (Annual)0.14x

ROI (5Y Avg)-107.56%

LT Debt / Equity (Quarterly)0.49x

EPS Basic Excl Extra (TTM)$-4.22

P/TBV (Quarterly)18.81x

P/B Ratio (Annual)9.37x

Pretax Margin (TTM)-1002.82%

Book Value / Share (Annual)$0.33

Price vs S&P 500 (13W)-52.94%

Beta1.07x

P/FCF (Annual)524.78x

Revenue / Share (TTM)$0.36

ROE (TTM)-376.59%

52-Week Low$1.91

vGradeC

gGradeA

mGradeF

vgmGradeC

Show chart for

Earnings Surprise History

Q1 26-0.97est. -0.73

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.92

4.00

3.91

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	Price
VNRXVolitionRx Limited	C	A	F	$2.65
IDXXIdexx Laboratories Inc	D	B	C	$566.79
LNTHLantheus Holdings, Inc	C	B	B	$97.13
NNNNAnbio Biotechnology Class A Ordinary Shares	F	B	A	$30.17
CLDXCelldex Therapeutics, Inc	F	F	B	$30.14
NTLAIntellia Therapeutics, Inc	D	C	B	$13.73
NEOGNeogen Corp	C	C	C	$8.92
QDELQuidelOrtho Corporation Common Stock	B	C	D	$13.27
ACHVAchieve Life Sciences, Inc.	F	F	B	$5.30
MYGNMyriad Genetics Inc	C	C	D	$4.28
TKNOAlpha Teknova, Inc. Common Stock	C	C	B	$5.37

About

VolitionRX Ltd develops blood-based diagnostic tests using its proprietary Nucleosomics platform to identify disease markers from circulating nucleosomes. The company's tests provide simple, cost-effective alternatives for diagnosing and monitoring cancers, sepsis, COVID-19, and other serious diseases. VolitionRX operates in both human and veterinary diagnostics, targeting underserved markets with accessible diagnostic solutions.